Why so many menopausal women are getting eating disorders. For LULU BANHAM it started with competitive mums... now she reveals the dark secret so many hide
The tape measure I pulled tight around my waist before getting on the scales is even crueller, recording an expansion of 1cm.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
22 minutes ago
- The Independent
Companies explore other uses for popular weight loss injections
Eli Lilly and Novo Nordisk 's GLP-1 drugs, including Mounjaro, Zepbound, Ozempic, and Wegovy, achieved over U$40 billion in combined sales last year. Both pharmaceutical companies are actively investigating and testing these drugs for a broader range of medical conditions beyond their current uses for diabetes and weight loss. New conditions under exploration include alcohol use disorder, Alzheimer's disease, heart failure, chronic kidney disease, and a type of fatty liver disease called non-alcoholic steatohepatitis. Significant developments include Ozempic's US approval for reducing kidney failure risk in diabetes patients and Zepbound's US approval for obstructive sleep apnea in December 2024. Novo Nordisk has indicated that increased competition and the emergence of copycat versions are expected to affect Wegovy sales this year.
The Guardian
23 minutes ago
- The Guardian
Sir David Nabarro obituary
Many young people start out wanting to make a difference. Sir David Nabarro, who has died aged 75, was unusual in recognising early on the power of synergy. Aged 17, he was the subject of a 1967 BBC documentary on volunteering when he spent a year as organiser of Youth Action, leading a group of 400 volunteers in York, between leaving Oundle public school and going to Oxford University to study medicine. That experience – coordinating efforts for maximum impact – presaged a life in public service spent urging, cajoling and commanding others to work together. After stints as a medical officer in Iraq and Nepal, and as a health and population adviser in Kenya, he joined the World Health Organization, and subsequently the UN, leading the responses to the 2004 Indian ocean tsunami, the 2014 Ebola outbreak in West Africa and the 2016 cholera outbreak in Haiti. But it was as the WHO's special envoy for Covid-19, one of six appointed by the director general, that Nabarro became best known in the UK. He described the pandemic as a 'health crisis unlike anything we have encountered in my professional experience'. He was early to advocate the use of masks and testing, tracing and isolating infected individuals, but courted controversy with his remarks on lockdowns – which he said were misquoted. He argued that lockdowns should be used as 'circuit breakers', as a reserve measure to temporarily slow the spread of the virus, buying time and allowing the NHS and similar institutions to reorganise, regroup and rebalance their resources and protect their workers. In an interview with BBC Radio 4 in 2020 he cautioned against a full national lockdown, describing it as a 'a very extreme restriction on economic and social life' that temporarily 'freezes the virus in place'. He added: 'You don't want to use those as your primary, and I stress primary, means of containment. Because in the end living with the virus as a constant threat means maintaining the capacity to find people with the disease and isolating them.' The primary measure, he thought, should be a robust test, trace and isolate system, with lockdown 'the reserve you use to take the heat out of the system when things are really bad'. As a lifelong champion of health equity, he was critical of the global response to the pandemic. He lamented the way that politics had begun shifting how governments responded to global health emergencies. In a 2021 interview with NPR, the US public radio network, he recalled how the global response to Ebola in 2014 had been 'amazing', but that by the time Covid-19 developed in 2020 things had changed. 'There has been a funny shift,' he said. 'I find world leaders are no longer apparently able to work together and deal with this through a global response.' Despite his disappointment he worked tirelessly to protect the UK and beyond from the pandemic, arguing forcefully for vaccine equity. 'The one thing we want [at the WHO] is every country in the world to be able to access a fair share of the vaccine,' he said. He was knighted in 2023. His kindness, humility and decency won loyalty from staff, though his work ethic could be challenging. He was the 'Gandalf of the UN', said Aurélia Nguyen of the Coalition for Epidemic Preparedness Innovations. He was 'always working behind the scenes for a broader purpose in ways that were not visible or needing to take credit but quietly bringing people to the table who otherwise would not speak to each other. He worked all hours relentlessly – some of his staff may say mercilessly – but with such conviction and passion it was impossible not to follow him.' Born in London, David was one of the four children of Sir John Nabarro, a consultant endocrinologist, and Joan (nee Cockrell). David was educated at Oundle school, Northamptonshire, before studying medicine at Worcester College, Oxford, and University College hospital, London. He joined WHO in 1999, working first on malaria and later, alongside the director-general Gro Harlem Brundtland on the creation of the global fund to fight Aids, tuberculosis and malaria, which has since saved millions of lives. In 2003 he survived the bombing of the Canal hotel in Baghdad while serving as WHO representative for health action in crises. He was appointed senior UN system coordinator for avian influenza (bird flu) in 2005, establishing him as a pioneer in pandemic preparedness. His most visible role on the international stage came in 2014 when he coordinated an unprecedented response to the Ebola outbreak in West Africa. Facing a situation where 'the number of people getting sick was doubling every week', he helped bring the epidemic under control by engaging the community, building trust and addressing social and economic factors alongside delivering medical aid. Championing the synergy between social and medical interventions stands as the legacy of his lifetime of service. In 2019 he became co-director, with me, of the Institute of Global Health Innovation at Imperial College London, a role to which he brought his vast operational experience, remarkable ability to build consensus among diverse stakeholders, and readiness to mentor young researchers. His office was always open to students and colleagues seeking guidance, and his generous spirit enriched the academic community. Nabarro is survived by his second wife, Florence Lasbennes, whom he married in 2019, and by five children – two sons and a daughter from a relationship with Susanna Graham-Jones, and a daughter and son from his marriage to Gillian Holmes, which ended in divorce – and seven grandchildren. David Nunes Nabarro, global health strategist, born 26 August 1949; died 26 July 2025
Daily Mail
23 minutes ago
- Daily Mail
Major supermarket urgently recalls popular chicken product over potential deadly allergy concerns
The budget supermarket Lidl has urgently recalled a popular chicken over concerns they contain an allergen not labelled. The product Red Hen 4 Tempura Chicken Steaks was pulled from shelves because it may contain milk which is not correctly named on the ingredient label. If you have bought the product and have an allergy or intolerance to milk, do not eat it and return it to the nearest Lidl store where a full refund will be given. The products affected are the pack size 380g with the best before dates 11/12/2026, 16/12/2026, 22/12/2026, 30/12/2026 and 16/01/2027. In a written statement, allergy charity anaphylaxis UK said they have been informed by the supermarket of the urgent recall. 'We have been alerted by Lidl that it is recalling its Red Hen 4 Tempura Chicken Steaks from sale because they contain milk which is not correctly declared on the ingredient label,' it read. So, they went on to explain: 'The product is therefore unsuitable for and should be avoided by anyone with an allergy or intolerance to milk.' When a supermarket is urgently recalling a product that contains an ingredient not named on a label, they often contact allergy charities. These charities can help inform the people with the relevant allergies of the product that may put them in danger. It comes just days after Waitrose recalled one of its ready-to-eat snack pots over fears it may be contaminated with salmonella. The dangerous bacteria is known to cause food poisoning, which in some cases can prove fatal. The item affected was the Waitrose and Partners Egg and Spinach Protein Pot, which comes in a 90g plastic tub and is sold in stores nationwide. Two batches were involved in the alert—those with use-by dates of July 31 and August 1, 2025. The supermarket has pulled the product from shelves and urged customers who have already bought it to not eat it. Instead, they should return it to a store for a full refund, with no receipt necessary. Point-of-sale notices have been displayed in affected stores warning shoppers of the risk. These explain the reason for the recall and what steps customers should take if they have purchased the item. The urgent recall issued was for the product Waitrose & Partners Egg & Spinach Protein Pot A spokesperson for the Food Standards Agency (FSA), which issued the alert, said: 'The presence of salmonella in this product poses a risk to human health... and can be particularly dangerous for the elderly, young children, and those with weakened immune systems.' Salmonella infection—known as salmonellosis—typically develops within six to 72 hours of consuming contaminated food. While many cases are mild and are resolved within a few days without treatment, more severe infections can lead to dehydration, hospitalisation, and in rare cases, death. Those with symptoms are advised to rest and drink plenty of fluids.
